David Bogoslaw
AI tools are helping consumer-focused fintech start-ups underwrite customer risk, sometimes in the absence of traditional banking or credit data.
VCs and corporate backers own shares currently worth nearly $10bn for VC-backed companies that have gone public this year – minus the holdings for outliers Circle and CoreWeave, which are valued at $35bn.
LPs in Longview’s North America University Innovations Fund include UK-based IP Group plc, institutional investors, large multi-family offices and prominent single-family offices.
Some seed funds are asking their LPs to support a larger number of investments, which typically means a fund will have smaller ownership of each company but will get more shots on goal.
The fund’s strategic and impact-oriented LPs include big pharma names such as Pfizer, Bristol Myers Squibb, AARP and Alzheimer’s Research UK, which are excited by improved scientific understanding of dementia that promise to increase clinical trial successes.
Nicole Musicco, former CIO of CalPERS, warns that evergreen funds may lead to a more transactional dynamic between manager and investor.
Fund III was anchored by Cendana Capital and includes commitments from Intact Ventures, Atacama Ventures, NVNG Investment Advisors and strategic investor Schreiber Foods.
The aviation investment manager plans to raise a new fund that will build on JetBlue Ventures’ existing portfolio and expand founders’ access to more strategic relationships around the world.
After nearly two decades in Apollo’s private equity division, Justin Stevens brings his relationships with debt and other structured finance providers to bear at Overlap Holdings.
The fund's private markets-style structure 'allows us to apply a venture capital mindset to publicly traded biotech companies,' says managing partner Gaurav Aggarwal.